The new suite extends GMP bioconjugate production for intermediates and active pharmaceutical ingredients from early clinical phase through to late clinical phases and commercial supply. Staad – Biosynth, a leading developer and supplier of critical raw materials and services for life sciences and diagnostics, is pleased to announce the opening of its expanded GMP bioconjugation […]

Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer generates results in as little as 24 hours to support timely therapy decisions CARLSBAD, Calif.–Thermo Fisher Scientific, the world leader in serving science, today announced the U.S. Food and Drug Administration (FDA) has approved the Oncomine™ Dx Express Test on the Ion Torrent™ […]

Auckland, New Zealand – MGI Tech Co., Ltd. (“MGI”), a company dedicated to developing core tools and technologies that drive innovation in life sciences, has joined efforts with Lincoln University in Canterbury to address sustainable challenges in viticulture through advanced sequencing technology. The initiative aims to utilize genomics to breed better varieties of grapevines and hops that […]

LINCOLN, NE and Heidelberg, Germany – LICORbio, a leading innovator in life science imaging and analytical solutions, today announced the acquisition of SERVA Electrophoresis, a privately held company known for its high-quality electrophoresis reagents, consumables, and workflow instrumentation. The transaction strengthens LICORbio’s position as a comprehensive solutions provider in protein analysis and enhances its commitment to […]

WESTMINSTER, CA / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, has commenced “alpha testing” of a PFAS-detecting portable water test kit developed by Verralize, Inc., an innovator of next-generation water testing technologies. Verralize’s “lab-on-a-sensor” test kit enables rapid, on-site detection of per- and polyfluoroalkyl […]

Expanding capabilities in delivering scalable, high-quality synthetic DNA solutions to the global market Cambridge, UK – 4basebio PLC (AIM: 4BB) (“4basebio”), a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, today announced refreshed branding and the launch of its new website, reflecting the company’s continued growth and success in this rapidly advancing field. […]

Saint-Germain-en-Laye, France – Takara Bio Europe is pleased to announce it has entered into a distribution agreement with MACHEREY-NAGEL (MN), a leading global provider of analytical and bioanalytical products. Under this agreement, Takara Bio Europe will distribute MN’s Bioanalysis portfolio in Austria, Belgium, Denmark, France, Germany, Ireland, Luxemburg, Sweden, Switzerland and the United Kingdom. MN’s Bioanalysis […]

Genovis AB (publ) (“Genovis”) today announces that it has exercised its call option to acquire the remaining 75% of SEQURNA AB (“SEQURNA” or “Company”), a strategic move that accelerates Genovis’ expansion into the fast-growing genomics sector. This acquisition unlocks new product offerings for Genovis to both existing and new customers and further paves the way […]

Financing to accelerate commercialization of flagship products, service business, and entrance into U.S. market STOCKHOLM — Epigenica AB, a pioneer in high-throughput epigenetic screening tools and solutions, announced today that it has closed a $2.2 million round (SEK 21.5M) to fuel its growth and commercial expansion across key markets. This round was led by Voima Ventures, a Nordic early-stage […]

WASHINGTON — Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Martin Stumpe will be appointed Chief Technology and AI Officer, effective October 1, 2025. He will report directly to Rainer Blair, President and Chief Executive Officer. This appointment marks a pivotal step in Danaher’s digital transformation and its ambition to lead the […]